BT02 / BioTroy Therap - LARVOL DELTA

A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma (clinicaltrials.gov) - P1 | N=58 | Not yet recruiting | Sponsor: Biotroy Therapeutics

New P1 trial • Melanoma • Oncology • Solid Tumor

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies (clinicaltrials.gov) - P1/2 | N=116 | Not yet recruiting | Sponsor: Biotroy Therapeutics

New P1/2 trial • Hematological Malignancies • Leukemia • Lymphoma • Multiple Myeloma • Oncology

A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer (clinicaltrials.gov) - P1 | N=58 | Not yet recruiting | Sponsor: Biotroy Therapeutics

New P1 trial • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor

Clinical Trial of BT02 in Patients With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=60 | Recruiting | Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Metastases • New P1 trial • Oncology • Solid Tumor